| Synonyms: | |
| Status: | Approved (2011) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AA26 |
| UNII: | 73B0K5S26A |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Tumor necrosis factor ligand superfamily member 13B inhibitor | DailyMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lupus Nephritis | 4 | D008181 | ClinicalTrials |
| Vasculitis | 3 | D014657 | ClinicalTrials |
| Sjogren's Syndrome | 2 | D012859 | ClinicalTrials |
| Purpura, Thrombocytopenic, Idiopathic | 2 | D016553 | ClinicalTrials |
| Myositis | 2 | D009220 | ClinicalTrials |
| Kidney Diseases | 2 | D007674 | ClinicalTrials |
| Emphysema | 2 | D004646 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Scleroderma, Systemic | 2 | D012595 | ClinicalTrials |
| Glomerulonephritis, Membranous | 2 | D015433 | ClinicalTrials |
| Graft vs Host Disease | 1 | D006086 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1789843 |
| FDA SRS | 73B0K5S26A |
CONTENTS